Diabetes is associated with high risk of severe adverse events during chemotherapy for cancer patients: A single‐center study

Author:

Mailliez Aurélie12ORCID,Ternynck Camille3,Duhamel Alain3,Mailliez Audrey4ORCID,Ploquin Anne5,Desauw Christophe5,Lemaitre Madleen67,Bertrand Nicolas5,Vambergue Anne67,Turpin Anthony89ORCID

Affiliation:

1. Department of Geriatrics CHU Lille Lille France

2. U1167‐RID‐AGE‐Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille Lille France

3. ULR 2694—METRICS: Évaluation Des Technologies De Santé Et Des Pratiques Médicales Université de Lille, CHU Lille Lille France

4. Medical Oncology Department, Breast Cancer Unit Oscar Lambret Center Lille France

5. Medical Oncology Department, CHU Lille, ULR 2694 METRICS University of Lille Lille France

6. CHU Lille, Department of Diabetology, Endocrinology, Metabolism and Nutrition Lille University Hospital Lille France

7. European Genomic Institute for Diabetes Lille University School of Medicine Lille France

8. CHU Lille, Institut Pasteur de Lille, UMR9020—UMR‐S 1277—Canther—Cancer Heterogeneity, Plasticity and Resistance to Therapies University of Lille, CNRS, Inserm Lille France

9. Medical Oncology Department, CHU Lille University of Lille Lille France

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3